These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7577315)
1. [ACE inhibitors in the treatment of patients with acute myocardial infarct]. Borghi C; Ambrosioni E Ann Ital Med Int; 1995; 10(3):175-87. PubMed ID: 7577315 [TBL] [Abstract][Full Text] [Related]
2. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)]. Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
4. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI]. Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514 [TBL] [Abstract][Full Text] [Related]
7. [Trandolapril in the prevention of the sequelae of left ventricular systolic dysfunction after acute myocardial infarct]. Buksa M Med Arh; 2000; 54(2):103-6. PubMed ID: 10934839 [TBL] [Abstract][Full Text] [Related]
8. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials. Saha SA; Molnar J; Arora RR J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946 [TBL] [Abstract][Full Text] [Related]
9. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials. Saha SA; Molnar J; Arora RR Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949 [TBL] [Abstract][Full Text] [Related]
10. [Trials with ACE-inhibitors in acute myocardial infarction]. Dalla Volta S Cardiologia; 1994 Dec; 39(12 Suppl 1):149-55. PubMed ID: 7634258 [TBL] [Abstract][Full Text] [Related]
11. [ACE inhibitors in the treatment of patients after myocardial infarct]. Widimský J Vnitr Lek; 1993 Jun; 39(6):527-35. PubMed ID: 8212605 [TBL] [Abstract][Full Text] [Related]
12. What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us? Reynolds G; Hall AS; Ball SG Eur J Clin Pharmacol; 1996; 49 Suppl 1():S35-9. PubMed ID: 8834930 [TBL] [Abstract][Full Text] [Related]
13. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study. Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A; Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011 [TBL] [Abstract][Full Text] [Related]
14. [Converting enzyme inhibitors and coronary failure]. Castaigne A; Saal JP; Albo C; Verschuren P; Pham I Rev Prat; 1992 Dec; 42(20):2568-73. PubMed ID: 1299942 [TBL] [Abstract][Full Text] [Related]